10Y UST5.24%+1.35%30Y MTG7.03%+1.15%SOFR3.90%VNQ$90.53-0.07%XLRE$41.34-0.02%FED FUNDS3.88%
Real Estate Trail
Institutional Press Wire
PR Newswire · Capital

Ontario Contributes $1.7 Million Investment to Advance Life Sciences Innovation at Piramal Pharma's Aurora Facility

Via PR Newswire · September 29, 2026
Compiled by Real Estate Trail Editorial · September 29, 2026

Why this matters

Capital markets activity continues to be defined by the rotation from bank balance sheets to non-bank lenders. Private credit funds have raised record dry powder; banks have tightened CRE underwriting standards for the sixth consecutive quarter. The result is a market where well-sponsored deals clear, and marginal credit pays a meaningful spread to do so. For LPs, the allocation conversation has shifted decisively toward real estate debt, with equity allocations being deployed more selectively into operator-led platforms.

Editorial analysis · Real Estate Trail Editorial

On the RET wire

  • Disclosed capital deal value tracked in September 2026: $22B across 46 reported transactions.

Computed from Real Estate Trail’s own tracked coverage

Excerpt from PR Newswire:
Piramal Pharma Solutions is investing over $5.3 million in its Aurora drug substance facility to upgrade site infrastructure. With its investment through the Life Sciences Scale-Up Fund, the Ontario government is supp…
Read the full article at PR Newswire →

External link. Real Estate Trail does not republish source content.

Related coverage — Capital